Publication | Open Access
Draft Genome Sequence of Streptomyces rapamycinicus Strain NRRL 5491, the Producer of the Immunosuppressant Rapamycin
48
Citations
8
References
2013
Year
Draft Genome SequenceImmunosuppressant RapamycinBiosynthesisEngineeringStrain Nrrl 5491Molecular BiologyImportant Drug RapamycinNatural Product BiosynthesisMicrobiologyMolecular MicrobiologyMetabolomicsSystems BiologyMedicineLarge GenomeClinical MicrobiologyAntimicrobial ResistanceMicrobial Genetics
Streptomyces rapamycinicus strain NRRL 5491 produces the important drug rapamycin. It has a large genome of 12.7 Mb, of which over 3 Mb consists of 48 secondary metabolite biosynthesis clusters.
| Year | Citations | |
|---|---|---|
Page 1
Page 1